Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain.
Candidemia studies have documented geographic differences in rates and epidemiology, underscoring the need for surveillance to monitor trends. We conducted prospective candidemia surveillance in Spain to assess the incidence, species distribution, frequency of antifungal resistance, and risk factors for acquiring a Candida infection. Prospective laboratory-based surveillance was conducted from June 2008 to June 2009 in 40 medical centers located around the country. A case of candidemia was defined as the isolation of a Candida species from a blood culture. Incidence rates were calculated per 1,000 admissions. Antifungal susceptibility tests were performed by using broth microdilution assay according to the guidelines of the Clinical and Laboratory Standards Institute. We detected 984 cases, for an overall incidence of 1.09 cases per 1,000 admissions. The crude mortality was 20.20%. Candida albicans was the most common species (49.08%), followed by C. parapsilosis (20.73%), C. glabrata (13.61%), and C. tropicalis (10.77%). Overall, decreased susceptibility to fluconazole occurred in 69 (7.01%) incident isolates. Antifungal resistance was rare, and a moderate linear correlation between fluconazole and voriconazole MICs was observed. This is the largest multicenter candidemia study conducted to date and shows the substantial morbidity and mortality of candidemia in Spain.
Cisterna
R
R
Basurto Hospital, Clinical Microbiology and Infection Control Department, Bilbao, Spain. ramon.cisternacancer@osakidetza.net
Ezpeleta
G
G
Telleria
O
O
Guinea
J
J
Regueiro
B
B
Garcia-Rodríguez
J
J
Esperalba
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000494:pharmacology; D002175:Candida / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D002177:Candidiasis / Q000453:epidemiology*; D002648:Child; D002675:Child, Preschool; D025141:Drug Resistance, Fungal; D005260:Female; D016469:Fungemia / Q000453:epidemiology* / Q000382:microbiology; D006761:Hospitals; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011446:Prospective Studies; D018571:Sentinel Surveillance; D013030:Spain / Q000453:epidemiology; D055815:Young Adult
D000935:Antifungal Agents
Saudi Med J. 2004 May;25(5):566-9
15138521
Clin Infect Dis. 1999 Nov;29(5):1164-70
10524958
Clin Infect Dis. 2001 Jul 15;33(2):177-86
11418877
Clin Infect Dis. 1992 Mar;14(3):756-66
1345554
Clin Infect Dis. 2004 Sep 1;39(5):743-6
15356792
Clin Infect Dis. 1996 Sep;23(3):506-14
8879773
J Med Microbiol. 2002 Aug;51(8):677-681
12171299
Clin Infect Dis. 1992 Sep;15(3):414-21
1520786
J Hosp Infect. 2000 May;45(1):69-72
10917780
Antimicrob Agents Chemother. 2005 Nov;49(11):4555-60
16251295
Infect Control Hosp Epidemiol. 1998 Nov;19(11):846-50
9831941
Eur J Clin Microbiol Infect Dis. 2002 Nov;21(11):767-74
12461585
J Clin Microbiol. 2009 Jun;47(6):1942-6
19386851
Arch Intern Med. 1995 Jun 12;155(11):1177-84
7763123
J Hosp Infect. 2002 Aug;51(4):297-304
12183145
Clin Microbiol Infect. 2002 Jul;8(7):405-12
12199850
Clin Infect Dis. 2004 Feb 1;38(3):311-20
14727199
J Clin Microbiol. 1998 Dec;36(12):3455-9
9817853
J Infect Dis. 1998 Feb;177(2):425-30
9466531
Med Mycol. 2004 Aug;42(4):333-9
15473358
Clin Infect Dis. 2003 Nov 1;37(9):1172-7
14557960
Infect Control Hosp Epidemiol. 2005 Jun;26(6):548-52
16018430
Medicine (Baltimore). 2002 Nov;81(6):425-33
12441899
J Clin Microbiol. 2004 Jul;42(7):3142-6
15243073
J Clin Microbiol. 2004 Oct;42(10):4468-72
15472295
Eur J Clin Microbiol Infect Dis. 2003 Apr;22(4):254-7
12709840
Infect Control Hosp Epidemiol. 2005 Jun;26(6):540-7
16018429
J Clin Microbiol. 2005 Apr;43(4):1829-35
15815004
Rev Inst Med Trop Sao Paulo. 2004 Sep-Oct;46(5):239-41
15517023
J Clin Microbiol. 2002 Apr;40(4):1298-302
11923348
Infect Control Hosp Epidemiol. 2005 Jun;26(6):553-8
16018431
Antimicrob Agents Chemother. 2003 Oct;47(10):3149-54
14506023
Clin Infect Dis. 1998 May;26(5):1086-8
9597232
Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):317-22
15029512
Rev Infect Dis. 1989 May-Jun;11(3):379-90
2749102
J Clin Microbiol. 1998 Jul;36(7):1886-9
9650930
Mycoses. 2002 Jun;45(5-6):141-5
12100528
Clin Infect Dis. 2002 Sep 1;35(5):627-30
12173140
J Infect Dis. 2000 Jan;181(1):309-16
10608780
Am J Med. 1991 Sep 16;91(3B):86S-89S
1928197
Eur J Clin Microbiol Infect Dis. 2000 Aug;19(8):602-7
11014622
Clin Infect Dis. 2003 Sep 1;37(5):634-43
12942393
Diagn Microbiol Infect Dis. 1999 Aug;34(4):281-6
10459478
J Clin Microbiol. 2002 Sep;40(9):3489-92
12202600